Gilbert SC, Lambe T. Recombinant protein vaccines against SARS-CoV-2. Lancet Infect Dis 2021; published online April 19. https://doi.org/10.1016/S1473-3099(21)00227-9—In this Comment the dose unit was incorrect. The dose unit should be “μg” rather than “mg”. This correction has been made to the online version as of April 23, 2021, and will be made to the printed version.
. 2021 Apr 23;21(6):e148. doi: 10.1016/S1473-3099(21)00265-6
Correction to Lancet Infect Dis 2021; published online April 19. https://doi.org/10.1016/S1473-3099(21)00227-9
Issue date 2021 Jun.
© 2021 Elsevier Ltd. All rights reserved.
Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
PMCID: PMC8064665 PMID: 33901417
This corrects the article "Recombinant protein vaccines against SARS-CoV-2" on page 1337.